Schuetz Thomas J. 4
4 · Compass Therapeutics, Inc. · Filed Feb 13, 2025
Insider Transaction Report
Form 4
Schuetz Thomas J.
DirectorCHIEF EXECUTIVE OFFICER
Transactions
- Award
Stock Option (Right to Buy)
2025-02-11+1,500,000→ 1,500,000 totalExercise: $3.65Exp: 2035-02-11→ CommonStock (1,500,000 underlying)
Footnotes (1)
- [F1]The options vest over 48 substantially equal monthly installments starting March 11, 2025.